Endocrinology Practice Questions

Q: In relation to type 1A Diabetes Mellitus, what characterizes the honeymoon period?

Insulin requirement is nil or modest. ### Explanation **The Medical Concept:** The "Honeymoon Period" (or partial remission phase) in Type 1A Diabetes Mellitus occurs shortly after the initiation of insulin therapy. It is characterized by a temporary recovery of the remaining beta-cell function. When exogenous insulin is started, it relieves "glucotoxicity," allowing the surviving beta cells to rest and resume endogenous insulin secretion. During this phase, blood glucose levels stabilize, and the patient’s **exogenous insulin requirement drops significantly (nil or <0.5 units/kg/day)** [1]. **Analysis of Options:** * **Option B (Correct):** During this phase, the endogenous insulin production is sufficient enough that the patient requires very little or no external insulin to maintain euglycemia. * **Option A (Incorrect):** Type 1A DM is characterized by absolute insulin deficiency due to autoimmune destruction. Oral hypoglycemic agents (like Sulfonylureas) are ineffective and not indicated, as the underlying pathology is not insulin resistance but a lack of insulin production [1]. * **Option C & D (Incorrect):** While weight gain can occur after starting insulin (due to the reversal of the catabolic state and osmotic diuresis), it is not the defining characteristic of the honeymoon period. The hallmark is the reduction in insulin dosage. **High-Yield Facts for NEET-PG:** * **Duration:** The honeymoon period typically starts within weeks of diagnosis and can last from a few months to 2 years. * **C-peptide:** During this phase, C-peptide levels (a marker of endogenous insulin) may temporarily rise. * **Clinical Warning:** It is vital to counsel patients that this is **not a cure**. Beta-cell destruction continues, and insulin requirements will eventually increase as the remaining beta-cell mass is exhausted. * **Diagnosis:** Type 1A is immune-mediated (GAD65, IA-2, or ZnT8 antibodies), whereas Type 1B is idiopathic.

Q: What is the appropriate treatment for a 42-year-old obese male presenting with a blood glucose of 450 mg/dL, urine albumin 2+, urine sugar 4+, and urine ketones 1+?

Insulin. **Explanation:** The patient presents with severe hyperglycemia (450 mg/dL) and **ketonuria** (urine ketones 1+). In the context of Type 2 Diabetes Mellitus, the presence of ketonuria—even if mild—indicates a state of significant insulin deficiency or glucose toxicity [1]. According to standard clinical guidelines (ADA/RSSDI), **Insulin** is the treatment of choice in the following scenarios: 1. **Severe Hyperglycemia:** Blood glucose ≥300 mg/dL or HbA1c >10%. 2. **Ketonuria/Ketoacidosis:** Presence of ketones signifies the need for immediate glycemic control that oral agents cannot provide [2]. 3. **Symptomatic Presentation:** Significant weight loss, polyuria, or polydipsia [1]. **Why other options are incorrect:** * **Glibenclamide & Glipizide (Sulfonylureas):** These are secretagogues that require functional beta cells. In a state of glucose toxicity (glucose >300 mg/dL), beta cells are "stunned," making these drugs ineffective in the acute phase. Hypoglycemia is a known side effect of these drugs [3]. * **Metformin:** While the first-line drug for obese Type 2 diabetics, it is contraindicated in patients with significant ketosis or acute metabolic instability due to the risk of lactic acidosis and its slow onset of action. **NEET-PG High-Yield Pearls:** * **Glucose Toxicity:** High glucose levels paradoxically inhibit insulin secretion. Insulin therapy "breaks" this cycle, after which the patient may potentially be transitioned back to oral hypoglycemic agents (OHAs). * **Urine Albumin 2+:** Suggests underlying diabetic nephropathy; however, the immediate priority is stabilizing the metabolic state. * **Management Priority:** In any diabetic patient with ketosis or suspected DKA/HHS, **Insulin** is always the definitive answer over OHAs [2].

Q: What is the Somogyi effect?

Morning hyperglycemia due to excessive insulin dosage.. ### Explanation The **Somogyi effect** (also known as "rebound hyperglycemia") is a physiological response to untreated nocturnal hypoglycemia. **1. Why Option B is Correct:** The phenomenon occurs when a patient receives an **excessive dose of evening insulin**. This leads to an undetected dip in blood glucose levels during the middle of the night (usually between 2:00 AM and 3:00 AM). In response to this hypoglycemia, the body triggers a massive release of **counter-regulatory hormones** (glucagon, epinephrine, cortisol, and growth hormone) [1]. These hormones stimulate gluconeogenesis and glycogenolysis [3], causing the blood glucose to "rebound" to high levels by the morning. Thus, the clinical presentation is **morning hyperglycemia** caused by **too much insulin** the night before. **2. Why Other Options are Incorrect:** * **Option A:** This describes the **Dawn Phenomenon**, where morning hyperglycemia occurs due to the natural circadian surge of growth hormone and cortisol without preceding hypoglycemia. * **Option C:** While excessive insulin causes nocturnal hypoglycemia, the Somogyi effect specifically refers to the *resultant* hyperglycemic rebound seen in the morning. * **Option D:** This is physiologically inaccurate; insulin resistance typically leads to hyperglycemia, not hypoglycemia. **3. NEET-PG High-Yield Pearls:** * **The Diagnostic Test:** To differentiate Somogyi from the Dawn Phenomenon, the patient must check their blood glucose at **3:00 AM**. [2] * **Low 3 AM glucose** = Somogyi Effect. * **High/Normal 3 AM glucose** = Dawn Phenomenon. * **Management:** For the Somogyi effect, the treatment is to **decrease the evening insulin dose** or provide a bedtime snack. * **Mnemonic:** "S" for Somogyi = "**S**o much insulin" or "**S**ipping" (dipping) at 3 AM.

Q: Which of the following is NOT a criterion for metabolic syndrome?

Fasting blood glucose between 100-125 mg/dL. The diagnosis of **Metabolic Syndrome** (also known as Syndrome X or Insulin Resistance Syndrome) is primarily based on the **NCEP ATP III criteria** (modified). To diagnose the syndrome, at least **three out of five** specific criteria must be met. ### Why Option B is the Correct Answer The criterion for hyperglycemia in metabolic syndrome is a **Fasting Blood Glucose (FBG) ≥ 100 mg/dL** (which includes both impaired fasting glucose and overt Diabetes Mellitus) **OR** being on medical treatment for elevated glucose [1]. Option B specifies a range (100–125 mg/dL); while this range falls under the definition, it is **not the threshold criterion**. Any value ≥ 100 mg/dL qualifies, making the specific range "100-125" technically incorrect as a formal definition [1]. ### Analysis of Other Options * **Option A (Triglycerides > 150 mg/dL):** This is a standard criterion. Hypertriglyceridemia (≥ 150 mg/dL) or being on treatment for the same is a core component. * **Option C (HDL 88 cm in women or > 102 cm in men):** These are the standard NCEP ATP III cut-offs for abdominal obesity. ### NEET-PG High-Yield Pearls 1. **Blood Pressure:** The threshold for metabolic syndrome is **≥ 130/85 mmHg** (Note: This is lower than the 140/90 threshold for diagnosing Hypertension). 2. **Ethnic Variations:** For **South Asians (Indians)**, the waist circumference cut-offs are lower: **> 90 cm in men** and **> 80 cm in women** (IDF criteria). 3. **Core Pathophysiology:** Insulin resistance and visceral obesity are the central drivers of this syndrome [2]. 4. **Prognosis:** Metabolic syndrome increases the risk of Type 2 Diabetes by 5-fold and Cardiovascular Disease by 2-fold [1].

Q: Which of the following is typically seen in Addison's crisis?

Hyperkalemia. Addisonian crisis (acute adrenal insufficiency) is a medical emergency caused by a severe deficiency of cortisol and aldosterone. The correct answer is **Hyperkalemia** due to the lack of aldosterone [4]. **1. Why Hyperkalemia is correct:** Aldosterone normally acts on the distal convoluted tubules and collecting ducts of the kidney to reabsorb sodium and water while excreting potassium and hydrogen ions [4]. In an Addisonian crisis, the absence of aldosterone leads to impaired potassium excretion, resulting in **hyperkalemia** and metabolic acidosis [4]. **2. Why the other options are incorrect:** * **Hypernatremia (A):** Incorrect. Due to the lack of aldosterone, there is "salt wasting" (loss of sodium in urine), leading to **hyponatremia**, not hypernatremia. * **Hyperglycemia (C):** Incorrect. Cortisol is a counter-regulatory hormone that promotes gluconeogenesis. Its deficiency leads to **hypoglycemia**. * **Hypertension (D):** Incorrect. The combination of mineralocorticoid deficiency (volume depletion) and glucocorticoid deficiency (decreased vascular tone) leads to severe **hypotension** and shock. **High-Yield Clinical Pearls for NEET-PG:** * **The "Classic Trio":** Hyponatremia, Hyperkalemia, and Hypoglycemia. * **Most common cause:** Sudden withdrawal of long-term steroid therapy (Secondary) [3] or autoimmune destruction (Primary/Addison’s) [1]. * **Immediate Management:** Do not wait for lab results. Administer **IV Hydrocortisone** (100mg bolus) and aggressive fluid resuscitation with **Normal Saline (0.9%)** [2]. * **Diagnosis:** The gold standard is the **ACTH Stimulation Test** (Cosyntropin test). In primary insufficiency, cortisol fails to rise [2].

Q: Zinc transporter 8 (ZnT8) antibody is seen in which of the following conditions?

Type 1 diabetes mellitus. **Explanation:** **Type 1 Diabetes Mellitus (T1DM)** is an autoimmune condition characterized by the destruction of pancreatic beta cells. **Zinc transporter 8 (ZnT8)** is a protein localized in the membrane of insulin secretory granules within these beta cells. It plays a critical role in transporting zinc into the granules, which is essential for the structural stabilization and crystallization of insulin hexamers. Antibodies against ZnT8 (ZnT8Ab) are one of the major autoantibodies used in the diagnosis of T1DM, alongside Glutamic Acid Decarboxylase (GAD65), Insulinoma-Associated Protein 2 (IA-2), and Insulin Autoantibodies (IAA). ZnT8Ab is particularly high-yield because it can be present even when other markers are negative, increasing the diagnostic sensitivity for T1DM. **Analysis of Incorrect Options:** * **Hashimoto's thyroiditis:** Associated with antibodies against thyroid peroxidase (anti-TPO) and thyroglobulin (anti-Tg). * **Hypoparathyroidism:** Often associated with antibodies against the calcium-sensing receptor (CaSR) in autoimmune cases (APS Type 1). * **Type A insulin resistance:** This is a genetic defect in the insulin receptor signaling pathway (e.g., INSR gene mutations), not an autoimmune process involving ZnT8. **High-Yield Clinical Pearls for NEET-PG:** * **ZnT8 (SLC30A8 gene):** Polymorphisms in this gene are also linked to an increased risk of Type 2 Diabetes. * **Diagnostic Utility:** ZnT8Ab is often the last antibody to appear before clinical onset and is a strong predictor of rapid progression to insulin dependence. * **LADA:** ZnT8 antibodies can also be found in patients with Latent Autoimmune Diabetes in Adults.

Question 1

A male patient presents with gynaecomastia, galactorrhoea, and hypogonadism. What is the likely diagnosis?

Accepted Answer

Prolactinoma

Answer

Empty sella syndrome

Answer

Meningioma

Answer

Acromegaly

Question 2

In relation to type 1A Diabetes Mellitus, what characterizes the honeymoon period?

Accepted Answer

Insulin requirement is nil or modest

Answer

Glycemic control achieved by oral hypoglycemic agents

Answer

Weight gain after insulin treatment

Answer

Weight loss after insulin treatment

Question 3

What is the appropriate treatment for a 42-year-old obese male presenting with a blood glucose of 450 mg/dL, urine albumin 2+, urine sugar 4+, and urine ketones 1+?

Accepted Answer

Insulin

Answer

Glibenclamide

Answer

Glipizide

Answer

Metformin

Question 4

What is the Somogyi effect?

Accepted Answer

Morning hyperglycemia due to excessive insulin dosage.

Answer

Morning hyperglycemia due to insulin resistance.

Answer

Morning hypoglycemia due to excessive insulin dosage.

Answer

Evening hypoglycemia due to insulin resistance.

Question 5

A 33-year-old lady presents with polydipsia and polyuria. Her symptoms started soon after a road traffic accident 6 months ago. The blood pressure is 120/80 mm Hg with no postural drop. The daily urinary output is 6-8 liters. Investigations showed Na 130 mEq/L, K 3.5 mEq/L, urea 15 mg/dL, sugar 65 mg/dL. The plasma osmolality is 268 mosmol/L and urine osmolality 45 mosmol/L. What is the most likely diagnosis?

Accepted Answer

Psychogenic polydipsia

Answer

Central diabetes insipidus

Answer

Nephrogenic diabetes insipidus

Answer

Resolving acute tubular necrosis

Question 6

Which of the following is NOT a criterion for metabolic syndrome?

Accepted Answer

Fasting blood glucose between 100-125 mg/dL

Answer

Triglycerides > 150 mg/dL

Answer

HDL cholesterol < 50 mg/dL in women or < 40 mg/dL in men

Answer

Waist circumference > 88 cm in women or > 102 cm in men

Question 7

Which of the following is typically seen in Addison's crisis?

Accepted Answer

Hyperkalemia

Answer

Hypernatremia

Answer

Hyperglycemia

Answer

Hypertension

Question 8

Polyglandular syndrome (Schmidt syndrome) is associated with adrenocortical deficiency and which of the following conditions?

Accepted Answer

Graves disease

Answer

Hypoparathyroidism

Answer

Hashimoto's thyroiditis

Answer

Islet cell adenoma

Question 9

A 65-year-old man presents with vision loss, headaches, cold intolerance, and unintentional weight gain of 5kg in 3 months. Examination reveals bitemporal hemianopia and a pulse of 50 bpm. A thyroid function test is ordered. Which of the following test results is most likely to be seen in this patient?

Accepted Answer

TSH: Low, Free T4: Low, Free T3: Low

Answer

TSH: High, Free T4: Low, Free T3: Low

Answer

TSH: High, Free T4: Normal, Free T3: Normal

Answer

TSH: Low, Free T4: High, Free T3: High

Question 10

Zinc transporter 8 (ZnT8) antibody is seen in which of the following conditions?

Accepted Answer

Type 1 diabetes mellitus

Answer

Hashimoto's thyroiditis

Answer

Hypoparathyroidism

Answer

Type A insulin resistance

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?